Exercise Capacity, Physical Fitness, and Physical Activity Levels in Children With CAH
NCT06449456 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 48
Last updated 2025-07-08
Summary
Congenital Adrenal Hyperplesia (CAH) is a group of automosal recessive disorders that develop due to a deficiency of one of the five enyzmes necessary for cortisol synthesis in the adrenal cortex. Research indicates a predisposition in children and adolescents with CAH towards adverse metabolic changes such as obesity, hypertension, insulin resistance and increased intima-media thickness. This study aims to compare the extent to which children and adolescents with CAH are effected in terms of respiratory and peripheral muscle strength, exercise capasity, physical fitness and physical activity levels compared o their matched healthy individuals.
Conditions
- Congenital Adrenal Hyperplasia
- Exercise Capacity
- Physical Activity
- Quality of Life
Sponsors & Collaborators
-
Hacettepe University
lead OTHER
Principal Investigators
-
Ebru CALIK KUTUKCU, PhD · Ankara, Hacettepe University, Türkiye, 06100 Contact: Phd 0903123051576 Ext.195 [email protected]
Eligibility
- Min Age
- 8 Years
- Max Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2024-02-22
- Primary Completion
- 2025-02-22
- Completion
- 2025-02-22
Countries
- Turkey (Türkiye)
Study Locations
More Related Trials
-
Questionnaire Study to Assess the Outcomes of the Management of Congenital Adrenal Hyperplasia Individuals
NCT05228652 ·Status: UNKNOWN
-
Natural History Study of Patients With Excess Androgen
NCT00250159 ·Status: RECRUITING
-
Growth Hormone (GH) in Congenital Adrenal Hyperplasia
NCT03162172 ·Status: COMPLETED
-
Exercise Capacity and Physical Activity Level in Prolactinoma Patients
NCT05236829 ·Status: COMPLETED
-
Continuous Subcutaneous Hydrocortisone Infusion in Congenital Adrenal Hyperplasia
NCT01771328 ·Status: UNKNOWN ·Phase: PHASE2
-
Phase II Study of Growth Hormone in Children With Cystic Fibrosis
NCT00016445 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of a Virtual Education-Based Transition Intervention to Improve Transition Readiness in Adolescent and Young Adults With Congenital Adrenal Hyperplasia
NCT05663320 ·Status: WITHDRAWN ·Phase: NA
-
Androgen Reduction in Congenital Adrenal Hyperplasia
NCT03548246 ·Status: WITHDRAWN ·Phase: PHASE2
-
Androgen Reduction in Congenital Adrenal Hyperplasia, Phase 1
NCT02574910 ·Status: TERMINATED ·Phase: PHASE1
-
Gonadal Changes In Congenital Adrenal Hyperplasia Patients
NCT04903587 ·Status: UNKNOWN
-
Cardiovascular Risk Profile in Patients With Congenital Adrenal Hyperplasia
NCT01807364 ·Status: COMPLETED
-
The Effects of Growth Hormone (GH) on Lipid Depots
NCT00491582 ·Status: COMPLETED ·Phase: NA
-
Hair Cortisol and Cushing's Disease
NCT04201444 ·Status: COMPLETED ·Phase: NA
-
Fertility and Pregnancy in Patients With Classic Congenital Adrenal Hyperplasia
NCT06153043 ·Status: COMPLETED
-
Molecular Basis of the Growth Axis in Short Stature
NCT00453245 ·Status: COMPLETED
-
A Trial of Lu AG13909 in Participants With Congenital Adrenal Hyperplasia
NCT05669950 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Comparison of Cortisol Pump With Standard Treatment for Congenital Adrenal Hyperplasia
NCT01859312 ·Status: COMPLETED ·Phase: PHASE2
-
The Hypothalamic-Pituitary-Adrenal (HPA) Axis as an Effector System in Weight Regulation
NCT00688987 ·Status: COMPLETED ·Phase: NA
-
Dexamethasone Treatment of Congenital Adrenal Hyperplasia
NCT00621985 ·Status: COMPLETED ·Phase: PHASE2
-
Growth Hormone Secretion Following the Anaerobic Exercise
NCT01934270 ·Status: UNKNOWN ·Phase: NA
-
Growth Parameters & Body Mass Index in Children With Chronic Diseases
NCT05801718 ·Status: UNKNOWN
-
Aryl Hydrocarbon Receptor Interacting Protein (AIP) Gene Mutations in Acromegaly
NCT01902420 ·Status: UNKNOWN
-
Fitness Level in Short Stature Children and After Growth Hormone Treatment
NCT02977091 ·Status: UNKNOWN
-
Effect of Cortisol on Physical Exertion in Patients With Primary Adrenal Failure
NCT01847690 ·Status: UNKNOWN ·Phase: PHASE2
-
Effect of Growth Hormone on Leptin, Cytokines and Body Composition of Children With Growth Failure Due to Chronic Kidney Disease
NCT00194961 ·Status: TERMINATED ·Phase: PHASE4